Michael Milligan
Patrimonio netto: 38 913 $ in data 31/05/2026
Patrimonio netto: 38 913 $ in data 31/05/2026
Michael Lee Milligan is currently Chief Financial Officer & Executive Vice President at New Haven Pharmaceuticals, Inc. and Chief Financial & Accounting Officer at Neumora Therapeutics, Inc. Former positions include Vice President Finance & Controller at Y-mAbs Therapeutics, Inc., Vice President-Finance & Controller at Acorda Therapeutics, Inc., and Chief Accounting Officer & Vice President at Shionogi, Inc. Education includes an MBA from Georgia State University and an undergraduate degree from the University of Miami.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/02/2026 | 21.034 ( 0,01% ) | 38 913 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 14/02/2025 |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Direttore Finanziario/CFO | - |
| Società | Posizione | Fine |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Comptroller/Controller/Auditor | - |
| YMAS THER | Comptroller/Controller/Auditor | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Georgia State University
Georgia State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale